Identifying the anti-inflammatory response to lipid lowering therapy. A position paper from the working group on Atherosclerosis and vascular biology of the European society of cardiology

Identifying the anti-inflammatory response to lipid lowering therapy. A position paper from the working group on Atherosclerosis and vascular biology of the European society of cardiology

Dysregulated lipid metabolism induces an inflammatory and immune response leading to atherosclerosis. Conversely, inflammation may alter lipid metabolism. Recent treatment strategies in secondary prevention of atherosclerosis support beneficial effects of both anti-inflammatory and lipid-lowering th...

Full description

Bibliographic Details
Main Authors:	Tunon, J, Badimon, L, Bochaton-Piallat, M, Carioua, B, Daemen, M, Egido, J, Evans, P, Hoefer, I, Ketelhuth, D, Lutgens, E, Matter, C, Monaco, C, Steffens, S, Stroes, E, Vindis, C, Weber, C, Back, M
Format:	Journal article
Published:	Oxford University Press 2018

Similar Items

Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice
by: Tuñón, J, et al.
Published: (2018)

Translational opportunities of single-cell biology in atherosclerosis
by: de Winther, MPJ, et al.
Published: (2022)

CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
by: Lutgens, E, et al.
Published: (2023)

Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk
by: Forteza, MJ, et al.
Published: (2023)

Cardiology
by: Banning, A, et al.
Published: (2009)

Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model
by: Arora, A, et al.
Published: (2022)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
by: Antonopoulos, A, et al.
Published: (2009)

Effects of niacin on atherosclerosis and vascular function.
by: Ruparelia, N, et al.
Published: (2011)

Functional diversity of vascular macrophages in atherosclerosis
by: Park, I
Published: (2018)

The role of indoleamine 2,3-dioxygenase (IDO) in the pathogenesis of non-alcoholic steatohepatitis (NASH) and atherosclerosis as comorbidities
by: Arora, A, et al.
Published: (2021)

Toll-like receptors in atherosclerosis.
by: Falck-Hansen, M, et al.
Published: (2013)

Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity
by: Cole, JE, et al.
Published: (2018)

Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis
by: Chen, Pei-Yu, et al.
Published: (2021)

Breaking the macrophage code in atherosclerosis
by: Monaco, C, et al.
Published: (2023)

Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.
by: Choudhury, R, et al.
Published: (2009)

Interrelationships between vascular superoxide and adiponectin biosynthesis in perivascular adipose tissue in human atherosclerosis
by: Bakogiannis, C, et al.
Published: (2010)

Is vascular superoxide triggering adiponectin biosynthesis in perivascular adipose tissue in patients with atherosclerosis?
by: Bakogiannis, C, et al.
Published: (2010)

Adiponectin as a regulator of vascular redox state in human atherosclerosis
by: Margaritis, M
Published: (2016)

Serum adiponectin regulates vascular O2-generation and NO bioavailability in patients with coronary atherosclerosis
by: Antoniades, C, et al.
Published: (2010)

Controversies in cardiology.
by: Taggart, D
Published: (2006)

Computers in cardiology
by: Computers in Cardiology Conference (1976 : St Louis, Missouri)
Published: (1976)

Cardiology essentials /
by: 256773 Holler, Teresa
Published: (2008)

Computers in Cardiology /
by: Computers in Cardiology Conference (1974: Maryland) 445895, et al.
Published: (1974)

Associations Between Serum Adiponectin, Vascular O2-Generation and NO Bioavailability In Patients With Coronary Atherosclerosis
by: Antoniades, C, et al.
Published: (2010)

An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.
by: McAteer, M, et al.
Published: (2010)

Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice.
by: Schmidt, T, et al.
Published: (2010)

CD200 limits monopoiesis and monocyte recruitment in atherosclerosis
by: Kassiteridi, C, et al.
Published: (2021)

Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans
by: Shami, A, et al.
Published: (2020)

Innate immunity and monocyte-macrophage activation in atherosclerosis.
by: Shalhoub, J, et al.
Published: (2011)

Telemedicine in pediatric cardiology
by: Maniar Urvi Dilip.
Published: (2008)

Current consult : cardiology /
by: Crawford, Michael H., et al.
Published: (2006)

Atlas of nuclear cardiology /
by: Narula, Jagat, et al.
Published: (2006)

Toll-like receptors and macrophage activation in atherosclerosis.
by: Seneviratne, A, et al.
Published: (2012)

The expression and functions of toll-like receptors in atherosclerosis.
by: Cole, J, et al.
Published: (2010)

Pediatric prevention of atherosclerosis: targeting early variation in vascular biology.
by: Leeson, P
Published: (2007)

Physical technique in cardiological imaging /
by: Short, M. D., et al.
Published: (1983)

Role Of Inflammatory Cells And Toll-Like Receptors In Atherosclerosis.
by: N Seneviratne, A, et al.
Published: (2013)

Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: another novel vascular protective mechanism?
by: Tousoulis, D, et al.
Published: (2008)

Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.
by: Antoniades, C, et al.
Published: (2004)

Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition
by: Akoumianakis, I, et al.
Published: (2020)